Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422]
- PMID: 38365538
- DOI: 10.1016/j.intimp.2024.111651
Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422]
Erratum for
-
Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis.Int Immunopharmacol. 2022 Dec;113(Pt B):109422. doi: 10.1016/j.intimp.2022.109422. Epub 2022 Nov 18. Int Immunopharmacol. 2022. PMID: 36410184
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous